Held in São Paulo, Brazil from July 29 to 31, 2026, SOLACI & SBHCI 2026 stands as the flagship annual event for cardiovascular intervention across Latin America. The conference brought together leading global specialists in panvascular intervention, clinicians and industry distributors. Through academic forums, hands-on training sessions and product exhibitions, participants explored new pathways for advancing cardiovascular care in the region.
High-Profile Exhibition Unlocks New Opportunities in South America’s Cardiovascular Industry
Kossel made a strong presence with its full portfolio of interventional devices. Backed by a comprehensive product lineup and established international certifications, the company stepped onto the Latin American stage to forge deeper connections with local stakeholders and accelerate the execution of its global strategy.
Demand for cardiovascular care continues to rise across South America. Clinicians are increasingly seeking cost-effective, one-stop interventional device solutions covering full clinical workflows, making the region a promising destination for innovative Chinese medical device manufacturers expanding overseas. Kossel has designated South America as a key strategic pillar of its global layout. By participating in this exhibition, the company targeted local market needs and consolidated distribution channels across Brazil, Argentina, Colombia and other countries, building a stable, long-term platform for regional dialogue and collaboration.
Leveraging years of global R&D and registration efforts, multiple products covering coronary, peripheral and electrophysiology segments have obtained authoritative MDR CE certifications, granting complete market access qualifications and laying a solid compliance foundation for sustained development in South America.
Booth Highlights: In-depth Discussions Uncover Collaboration Opportunities
Kossel’s all-inclusive panvascular interventional portfolio drew constant inquiries from professional visitors and earned widespread industry attention. On-site team members elaborated on the design merits, intraoperative performance and long-term cost-effectiveness of Kossel devices, addressing key clinical challenges prevalent in South America.
The exhibition strengthened overseas partners’ recognition of Kossel’s innovative devices while gathering valuable frontline clinical feedback. Such insights support targeted overseas product optimization and localized R&D improvements, creating mutual value for product iteration and regional market expansion.
Rooted in São Paulo, with a vision for broader South America and beyond, Kossel will continue delivering high-quality innovative panvascular interventional devices, deepen international partnerships across South America and worldwide, and bring advanced Chinese medical technology to benefit more patients and clinicians